Skip to main content
Top
Published in: Modern Rheumatology 3/2009

01-06-2009 | Original Article

Ankylosing enthesitis associated with up-regulated IFN-γ and IL-17 production in (BXSB × NZB) F1 male mice: a new mouse model

Authors: Yasuharu Abe, Mareki Ohtsuji, Naomi Ohtsuji, Qingshun Lin, Hiromichi Tsurui, Susumu Nakae, Toshikazu Shirai, Katsuko Sudo, Sachiko Hirose

Published in: Modern Rheumatology | Issue 3/2009

Login to get access

Abstract

We found that in contrast to (BXSB × NZB) F1 female mice that spontaneously develop severe systemic lupus erythematosus (SLE), male (BXSB × NZB) F1 mice are not prone to SLE, but instead develop seronegative ankylosing enthesitis in ankle/tarsal joints only when caged in groups, with the incidence reaching 83% at 7 months of age. This ankylosis is microscopically characterized by a marked proliferation of fibroblast-like cells positive for bone morphogenetic protein (BMP)-2 in association with heterotropic formation of cartilages and bones in hyperplastic entheseal tissues and subsequent fusion of tarsal bones. Elevated potentials of popliteal lymph node T cells producing interleukin (IL)-17 and interferon (IFN)-γ were significantly associated with joint ankylosis, suggesting the involvement of these cytokines in effector phase mechanisms of the disease, including up-regulated BMP signaling pathways. There was no difference in serum autoantibody levels between affected and unaffected mice. Parental BXSB and NZB strains of both sexes did not develop the disease even when caged in groups, indicating that the disease develops under the control of susceptibility genes derived from both parental strains. These results indicate that (BXSB × NZB) F1 male mice are a suitable model for clarifying genetic, environmental and molecular mechanisms underlying ankylosing enthesitis and related diseases.
Literature
1.
go back to reference Kataria R, Brent LH. Spondyloarthropathies. Am Fam Physician. 2004;69:2853–60.PubMed Kataria R, Brent LH. Spondyloarthropathies. Am Fam Physician. 2004;69:2853–60.PubMed
2.
go back to reference Reveille JD, Arnett FC. Spondyloarthritis: update on pathogenesis and management. Am J Med. 2005;118:592–603.PubMedCrossRef Reveille JD, Arnett FC. Spondyloarthritis: update on pathogenesis and management. Am J Med. 2005;118:592–603.PubMedCrossRef
3.
4.
go back to reference Benjamin M, McGonagle D. The anatomical basis for disease localization in seronegative spondyloarthropathy at enthuses and related sites. J Anat. 2001;199:503–26.PubMedCrossRef Benjamin M, McGonagle D. The anatomical basis for disease localization in seronegative spondyloarthropathy at enthuses and related sites. J Anat. 2001;199:503–26.PubMedCrossRef
5.
go back to reference Francois RJ, Braun J, Khan MA. Entheses and enthesitis: a histopathologic view and relevance to spondyloarthritides. Curr Opin Rheumatol. 2001;13:255–64.PubMedCrossRef Francois RJ, Braun J, Khan MA. Entheses and enthesitis: a histopathologic view and relevance to spondyloarthritides. Curr Opin Rheumatol. 2001;13:255–64.PubMedCrossRef
6.
go back to reference Murphy ED, Roths JB. A Y chromosome associated factor in strain BXSB promoting accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 1979;22:1188–94.PubMedCrossRef Murphy ED, Roths JB. A Y chromosome associated factor in strain BXSB promoting accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 1979;22:1188–94.PubMedCrossRef
7.
go back to reference Shirai T, Hirose S, Okada T, Nishimura H. Immunology and immunopathology of the autoimmune disease of NZB and related mouse strains. In: Rihova B, Vetvicka V, editors. Immunological disorders in mice. Boca Raton: CRC Press; 1991. p. 95–136. Shirai T, Hirose S, Okada T, Nishimura H. Immunology and immunopathology of the autoimmune disease of NZB and related mouse strains. In: Rihova B, Vetvicka V, editors. Immunological disorders in mice. Boca Raton: CRC Press; 1991. p. 95–136.
8.
go back to reference Izui S, Ibnou-Zekri N, Fossati-Jimack L, Iwamoto M. Lessons from BXSB and related mouse models. Int Rev Immunol. 2000;19:447–72.PubMedCrossRef Izui S, Ibnou-Zekri N, Fossati-Jimack L, Iwamoto M. Lessons from BXSB and related mouse models. Int Rev Immunol. 2000;19:447–72.PubMedCrossRef
9.
go back to reference Xiu Y, Nakamura K, Abe M, Li N, Wen XS, Jiang Y, et al. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J Immunol. 2002;169:4340–6.PubMed Xiu Y, Nakamura K, Abe M, Li N, Wen XS, Jiang Y, et al. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J Immunol. 2002;169:4340–6.PubMed
10.
go back to reference Sweet HO, Green MC. Progressive ankylosis, a new skeletal mutation in the mouse. J Hered. 1981;72:87–93.PubMed Sweet HO, Green MC. Progressive ankylosis, a new skeletal mutation in the mouse. J Hered. 1981;72:87–93.PubMed
11.
go back to reference Holmdahl R, Jansson L, Andersson M, Jonssos R. Genetic, hormonal and behavioural influence on spontaneously developing arthritis in normal mice. Clin Exp Immunol. 1992;88:467–72.PubMed Holmdahl R, Jansson L, Andersson M, Jonssos R. Genetic, hormonal and behavioural influence on spontaneously developing arthritis in normal mice. Clin Exp Immunol. 1992;88:467–72.PubMed
12.
go back to reference Nording C, Karlsson-Parra A, Jonsson L, Holmdahl R, Klareskog L. Characterization of a spontaneously occurring arthritis in male DBA/1 mice. Arthritis Rheum. 1992;35:717–22.CrossRef Nording C, Karlsson-Parra A, Jonsson L, Holmdahl R, Klareskog L. Characterization of a spontaneously occurring arthritis in male DBA/1 mice. Arthritis Rheum. 1992;35:717–22.CrossRef
13.
go back to reference Corthay A, Hansson A-S, Holmdahl R. T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse. Arthritis Rheum. 2000;43:844–51.PubMedCrossRef Corthay A, Hansson A-S, Holmdahl R. T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse. Arthritis Rheum. 2000;43:844–51.PubMedCrossRef
14.
go back to reference Matthys P, Lories RJ, De Klerck B, Heremans H, Luyten FP, Billiau A. Dependence on interferon-γ for the spontaneous occurrence of arthritis in DBA/1 mice. Arthritis Rheum. 2003;48:2983–8.PubMedCrossRef Matthys P, Lories RJ, De Klerck B, Heremans H, Luyten FP, Billiau A. Dependence on interferon-γ for the spontaneous occurrence of arthritis in DBA/1 mice. Arthritis Rheum. 2003;48:2983–8.PubMedCrossRef
15.
go back to reference Lories RJU, Matthys P, de Vlam K, Luyten FP. Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis. 2004;63:595–8.PubMedCrossRef Lories RJU, Matthys P, de Vlam K, Luyten FP. Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis. 2004;63:595–8.PubMedCrossRef
16.
go back to reference Weinreich S, Eulderink F, Capkova J, Pla M, Gaede K, Hessemenn J, et al. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol. 1995;42:103–15.PubMedCrossRef Weinreich S, Eulderink F, Capkova J, Pla M, Gaede K, Hessemenn J, et al. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol. 1995;42:103–15.PubMedCrossRef
17.
go back to reference Weinreich S, Capkova J, Hoebe-Hewryk B, Boog C, Ivanyi P. Grouped caging predisposes male mice to ankylosing enthesopathy. Ann Rheum Dis. 1996;55:645–7.PubMedCrossRef Weinreich S, Capkova J, Hoebe-Hewryk B, Boog C, Ivanyi P. Grouped caging predisposes male mice to ankylosing enthesopathy. Ann Rheum Dis. 1996;55:645–7.PubMedCrossRef
18.
go back to reference Mori S, Zhang M-C, Tanda N, Date F, Nose M, Furukawa H, et al. Genetic characterization of spontaneous ankylosing arthropathy with unique inheritance from Fas-deficient strains of mice arthritis. Ann Rheum Dis. 2006;65:1273–8.PubMedCrossRef Mori S, Zhang M-C, Tanda N, Date F, Nose M, Furukawa H, et al. Genetic characterization of spontaneous ankylosing arthropathy with unique inheritance from Fas-deficient strains of mice arthritis. Ann Rheum Dis. 2006;65:1273–8.PubMedCrossRef
19.
go back to reference Nakamura K, Kashiwazaki S, Takagishi K, Tsukamoto Y, Morohoshi Y, Nakano T, et al. Spontaneous degenerative polyarthritis in male New Zealand black mice. Arthritis Rheum. 1991;34:171–9.PubMedCrossRef Nakamura K, Kashiwazaki S, Takagishi K, Tsukamoto Y, Morohoshi Y, Nakano T, et al. Spontaneous degenerative polyarthritis in male New Zealand black mice. Arthritis Rheum. 1991;34:171–9.PubMedCrossRef
20.
go back to reference Lories RJU, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest. 2005;115:1571–9.PubMedCrossRef Lories RJU, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest. 2005;115:1571–9.PubMedCrossRef
21.
go back to reference Zoricic S, Maric I, Bobinac D, Vukicevic S. Expression of bone morphogenic proteins and cartilage-derived morphogenic proteins during osteophyte formation in humans. J Anat. 2003;202:269–77.PubMed Zoricic S, Maric I, Bobinac D, Vukicevic S. Expression of bone morphogenic proteins and cartilage-derived morphogenic proteins during osteophyte formation in humans. J Anat. 2003;202:269–77.PubMed
22.
go back to reference Dolhain RJ, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:1961–9.PubMedCrossRef Dolhain RJ, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:1961–9.PubMedCrossRef
23.
go back to reference Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human Interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999;42:963–70.PubMedCrossRef Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human Interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999;42:963–70.PubMedCrossRef
24.
go back to reference Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183:2593–603.PubMedCrossRef Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183:2593–603.PubMedCrossRef
25.
go back to reference Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Springgs MK, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol. 1995;155:5483–6.PubMed Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Springgs MK, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol. 1995;155:5483–6.PubMed
26.
go back to reference Rifas I. T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization. J Cell Biochem. 2006;98:706–14.PubMedCrossRef Rifas I. T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization. J Cell Biochem. 2006;98:706–14.PubMedCrossRef
Metadata
Title
Ankylosing enthesitis associated with up-regulated IFN-γ and IL-17 production in (BXSB × NZB) F1 male mice: a new mouse model
Authors
Yasuharu Abe
Mareki Ohtsuji
Naomi Ohtsuji
Qingshun Lin
Hiromichi Tsurui
Susumu Nakae
Toshikazu Shirai
Katsuko Sudo
Sachiko Hirose
Publication date
01-06-2009
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 3/2009
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-009-0166-0

Other articles of this Issue 3/2009

Modern Rheumatology 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.